Search the Newsreel

DarioHealth Corp. (DRIO) Gains 2.07% as Shares Test Key Resistance Zone - Hidden Order

DarioHealth Corp (NASDAQ: DRIO) Share Price, DRIO Stock News, DRIO Share Price & Updates

DarioHealth Earnings Call Highlights Margin Gains, ARR Strength

DARIOHEALTH CORP : ALLIANCE GLOBAL PARTNERS INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $12

Alliance Global Partners has initiated coverage on DarioHealth Corp (DRIO.O) with a "Buy" rating. The firm has set a target price of $12 for DarioHealth's stock. This news indicates a positive outlook from Alliance Global Partners for the digital health company.

DarioHealth (NASDAQ:DRIO) Now Covered by Analysts at Alliance Global Partners

Alliance Global Partners has initiated coverage on DarioHealth (NASDAQ:DRIO) with a "buy" rating and a $12 price target, suggesting a potential 67.13% upside. Despite this, analyst opinions remain mixed, resulting in a consensus "Hold" rating and an average target price of $10 for the …

DarioHealth Number of Employees 2026 | Employee Count & Headcount Data

DarioHealth Corp. (DRIO) had approximately 165 employees worldwide as of March 2026, marking a 31.5% decline from 241 employees in 2023. The company is actively hiring, with 16 active job postings in 2026, though this represents a 43.9% decline from 2025. Employee sentiment is …

Some Analysts Just Cut Their DarioHealth Corp. (NASDAQ:DRIO) Estimates

DarioHealth Corp. (NASDAQ:DRIO) recently saw its 2026 revenue estimates cut by analysts from US$26m to US$22m, though loss per share forecasts remained stable at US$3.99. This revision suggests a more conservative outlook, with expected sales growth now significantly slower than the industry average. The …

Analysts Have Made A Financial Statement On DarioHealth Corp.'s (NASDAQ:DRIO) Second-Quarter Report

DarioHealth Corp. (NASDAQ:DRIO) recently reported its second-quarter results, showing a revenue miss but a smaller-than-expected per-share loss. Analysts have since revised their forecasts, significantly cutting revenue expectations for 2026 while also reducing estimated losses. Despite these adjustments, the consensus price target remains largely unchanged, …

AI Chronic Care Platform Adds Fifth Fortune 50 Client, Lifts Margin to 62%

DarioHealth Corp. (DRIO:NASDAQ) reported strong Q2 2026 results, with revenue reaching $5.2 million and gross margin increasing to 62%. The AI-powered chronic care platform secured its fifth Fortune 50 client and expanded into provider-backed care, contributing to a contracted annual recurring revenue (ARR) of …

DarioHealth Reports Q2 Revenue, with 62% Gross Margin as AI Platform Expands

DarioHealth (DRIO:NASDAQ) reported its Q2 2026 financial results, showing US$5.2 million in revenue and a strong 62% gross margin, up from 55% in Q2 2025. The company achieved US$13.1 million in contracted and late-stage annual recurring revenue (ARR) and significantly reduced operating expenses by …

DarioHealth (NASDAQ:DRIO) Price Target Lowered to $8.00 at TD Cowen

TD Cowen has reduced its price target for DarioHealth (NASDAQ:DRIO) to $8.00 from $11.00, maintaining a "hold" rating, suggesting a potential upside of 3.76% from its current stock price. This adjustment comes despite DarioHealth reporting a narrower-than-expected loss in its latest quarter, though revenue …

DarioHealth Corp (DRIO) Q2 2026 Earnings Report Preview: What To Look For

DarioHealth Corp (DRIO) is scheduled to release its Q2 2026 earnings on August 12, 2026. Analysts expect Q2 revenue of $5.92 million and earnings of -$1.22 per share, with full-year 2026 estimates at $26.18 million revenue and -$3.96 earnings per share. Despite a slight …

DarioHealth Corp (DRIO) (Q2 2026) Earnings Call Highlights: Multi-Condition Platform Drives ...

Key Points Interested in DarioHealth Corp.? Here are five stocks we like better. Q2 revenue fell to $5.2 million as DarioHealth continued moving away from pharmaceutical services toward recurring B2B2C revenue, but gross margin improved to 62% and net loss narrowed to $7.9 million. …

DarioHealth Corp. Q2 2026 Earnings Call Summary

DarioHealth Corp. Q2 2026 Earnings Call Summary - Moby Strategic Evolution and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

DarioHealth Reports Second Quarter 2026 Financial Results

DarioHealth (NASDAQ: DRIO) announced its Q2 2026 financial results, reporting revenue of $5.2 million and a gross margin increase to 62%. The company saw an 11% quarter-over-quarter and 30% year-over-year decrease in operating loss, alongside a 21% year-over-year decline in operating expenses, indicating improved …

DarioHealth (NASDAQ:DRIO) Issues Quarterly Earnings Results, Beats Estimates By $0.37 EPS

DarioHealth Q2 Earnings Call Highlights

Key Points Interested in DarioHealth Corp.? Here are five stocks we like better. Q2 revenue fell to $5.2 million as DarioHealth continued moving away from pharmaceutical services toward recurring B2B2C revenue, but gross margin improved to 62% and net loss narrowed to $7.9 million. …

Earnings call transcript: DarioHealth tops q2 2026 EPS forecast, misses revenue

DarioHealth (DRIO) reported a narrower-than-expected loss in Q2 2026, beating EPS forecasts by 32% with adjusted earnings of negative $0.85 per share, but missed revenue estimates at $5.18 million. The company's stock rose 4.93% after the announcement, driven by improved gross margins (62%) and …

DarioHealth earnings beat by $0.40, revenue fell short of estimates

DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates

DarioHealth Corp. 2Q 2026: Revenue $5.18M, Net loss $7.92M — 10-Q Summary

DarioHealth Corp. reported a Q2 2026 revenue of $5.18 million, a slight decrease from the previous year, but significantly improved its net loss to $7.92 million from $18.56 million in Q2 2025. The company saw a shift towards B2B revenue, now comprising 75% of …

CoreWeave’s Forecast Is Key to Stopping Another Earnings Selloff

(Bloomberg) -- CoreWeave Inc. shares have been on a roll lately after a monthslong slump. Now, the neocloud provider's earnings after the close Tuesday can give investors a sense of whether the rally is sustainable. Most Read from Bloomberg China Unleashes $28 Trillion Capital …

DarioHealth Q2 Results: Adj. EPS beats estimates, sales miss

DARIOHEALTH Q2 2026 Earnings Preview: Recent $DRIO Insider Trading, Hedge Fund Activity, and More

DarioHealth Corp expected to post a loss of $1.21 a share - Earnings Preview

DarioHealth Corp is anticipated to report an upcoming earnings loss. Analysts predict the company will post a loss of $1.21 per share. This information is based on an earnings preview from Refinitiv.

Digital Health Provider Launches Women's Health & Sleep Solutions

DarioHealth Corp. (DRIO:NASDAQ) has introduced new "Dario Women" and "Dario Sleep" programs, expanding its cardiometabolic platform to address women's health during perimenopause and menopause, and obstructive sleep apnea. These additions cater to the growing demand from large employers and health plans for integrated digital …

DarioHealth Expands Platform with New Sleep and Women’s Health Solutions

DarioHealth has launched two new programs, Dario Women and Dario Sleep, to expand its cardiometabolic platform. These programs aim to address obstructive sleep apnea and menopause-related sleep disruptions, which are significant contributors to cardiometabolic disease. The new offerings provide integrated care combining AI-powered engagement, …

About 2.5× Higher Costs for Untreated Sleep Apnea; Dario Launches Care

DarioHealth (NASDAQ: DRIO) has launched two new provider-backed programs, Dario Women™ and Dario Sleep™, expanding its AI-enabled cardiometabolic platform to address women's health and obstructive sleep apnea (OSA). These programs integrate AI, human coaching, and licensed healthcare providers, aiming for rollout to clients in …

DarioHealth (DRIO) Projected to Release Quarterly Earnings on Tuesday

Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand – Company Announcement - FT.com

DarioHealth Corp. has expanded its cardiometabolic platform by introducing Dario Women™ and Dario Sleep™ solutions to address client demand for multi-condition offerings. These new programs integrate AI-powered engagement, behavioral coaching, and access to licensed healthcare providers to improve outcomes for women's health concerns like …

DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026

DarioHealth Corp. (Nasdaq: DRIO) announced it will release its second-quarter 2026 financial results on Tuesday, August 11, 2026, before market open. The AI-powered healthcare technology company will host a conference call and webcast at 8:30 a.m. Eastern Time, featuring its CEO, COO, and CFO …

DarioHealth launches women’s health and sleep programs By Investing.com

DarioHealth Corp. (NASDAQ:DRIO) has announced the launch of two new programs, Dario Women and Dario Sleep, expanding its cardiometabolic healthcare platform. These programs integrate digital engagement, behavioral coaching, and clinical care, targeting women's health during perimenopause and menopause, and obstructive sleep apnea. Both are …

Digital Health Firm Launches Integrated GLP-1 Program

DarioHealth Corp. (DRIO:NASDAQ) has launched an Integrated GLP-1 Program, combining its digital platform with Beluga Health's clinical oversight to offer end-to-end support for GLP-1 therapies, including evaluation, prescribing, and chronic care management. This program aims to address the rapidly growing GLP-1 market, targeting employers …